Neurology

The transition to standard time was associated with a transient increase in self-reported sleep disorders, while no problems with sleep were reported after the transition to daylight saving time, according to data in Neurology.

Stroke is the fifth leading cause of death in the U.S., responsible for more than 160,000 deaths yearly, and is strongly tied to heart disease, the leading cause of death, which is responsible for nearly 25% of deaths, according to the CDC.

CHICAGO — Igor J. Koralnik, MD, discusses highlights from his presentation at the 2022 American Neurological Association’s annual meeting on long COVID and its effect on the nervous system.

CHICAGO — Roy H. Hamilton, MD, MS, discusses a symposium at the 2022 American Neurological Association’s annual meeting that focused on Alzheimer’s disease and MS and the disproportionate burden that underrepresented groups experience.

CHICAGO – Jennifer A. Frontera, MD, professor of neurology at NYU School of Medicine, discussed possible therapeutic strategies for those with long COVID who are experiencing neurological symptoms at ANA 2022.

Empyrean Neuroscience Inc. has announced its launch as a genetic engineering company dedicated to developing fungi- and plant-based therapeutics for the treatment of neuropsychiatric and neurologic disorders.

A 7-year-old boy was referred to the neuro-ophthalmology clinic at the New England Eye Center for evaluation of decreased vision in the right eye.

Fortunately, in recent years, migraine has gained wider public and provider recognition as a complex and serious, chronic neurological disease that can profoundly impact a person’s quality of life.

In this edition, FDA votes to support approval of ALS therapy; partnership offers military veterans access to psychedelics; epidural steroid injections as alternate pain management options and more.